Robotic surgery and teleoperation are not good places to promise a replacement controller. The safety envelope, validation burden, and regulatory path are too serious. A more realistic starting point is residual-error assist in simulators, training systems, research teleoperation, and device-evaluation software.

The surgical-style TightLoop line focuses on screen motion, tool tremor, overcorrection, and command jitter. The product mode is adaptive assist: keep the baseline control path as the guardrail and add a gated residual correction layer only where the baseline leaves motion that can be reduced.

The relevant internal result came from a live surgical/tool stream style fixture. The baseline mean tool-motion error was 0.001010. Adaptive assist reduced it to 0.000407, a 2.48x mean reduction, while large spikes improved by 5.05x at p95. The sales angle is not raw RMS alone. It is spike suppression while preserving calm behavior.

That distinction matters because a controller that improves average error but creates rare large moves is not useful in a human-machine workflow. The product must be judged by tail behavior, latency, saturation, and fail-safe gating.

The deployment path should therefore start outside regulated clinical integration. A customer can provide recorded command, feedback, and measured tool result streams. TightLoop can replay those traces and report whether the residual correction reduces tremor and overcorrection without increasing tail risk.

In other words: do not sell “AI surgery.” Sell a measurable residual-motion audit for teleoperation systems that already exist.